{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T04:17:04Z","timestamp":1783138624861,"version":"3.54.6"},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,7,1]]},"DOI":"10.2169\/internalmedicine.6294-25","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:07:14Z","timestamp":1762985234000},"page":"1773-1778","source":"Crossref","is-referenced-by-count":0,"title":["Postpartum Hepatitis B Exacerbation Following Discontinuation of Nucleotide Analogue Therapy"],"prefix":"10.2169","volume":"65","author":[{"given":"Ryo","family":"Takada","sequence":"first","affiliation":[{"name":"Department of Hepatology, Kiryu Kosei General Hospital, Japan"},{"name":"Department of Gastroenterology and Hepatology, Gunma University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Kiryu Kosei General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Gunma University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeo","family":"Tateyama","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Gunma University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Fukuchi","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Kiryu Kosei General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuma","family":"Murakami","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Gunma University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Tojima","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Gunma University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Division of Virology, Department of Infection and Immunity, Jichi Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Uraoka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Gunma University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. The Japan Society of Hepatology. Hepatitis B Treatment Guidelines. 4th ed. 2022 [Internet]. Available from: https:\/\/www.jsh.or.jp\/lib\/files\/medical\/guidelines\/jsh_guidlines\/B_v4.pdf"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Usuda S, Okamoto H, Iwanari H, et al. Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product. J Virol Methods 80: 97-112, 1999.","DOI":"10.1016\/S0166-0934(99)00039-7"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Mulyanto, Depamede SN, Surayah K, et al. Identification and characterization of novel hepatitis B virus subgenotype C10 in Nusa Tenggara, Indonesia. Arch Virol 155: 705-715, 2010.","DOI":"10.1007\/s00705-010-0628-x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Tamura K, Stecher G, Kumar S. MEGA11: molecular evolutionary genetics analysis version 11. Mol Biol Evol 38: 3022-3027, 2021.","DOI":"10.1093\/molbev\/msab120"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. McNaughton AL, Revill PA, Littlejohn M, Matthews PC, Ansari MA. Analysis of genomic-length HBV sequences to determine genotype and subgenotype reference sequences. J Gen Virol 101: 271-283, 2020.","DOI":"10.1099\/jgv.0.001387"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Bui TTT, Tran TT, Nghiem MN, et al. Molecular characterization of hepatitis B virus in Vietnam. BMC Infect Dis 17: 601, 2017.","DOI":"10.1186\/s12879-017-2697-x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Parekh S, Zoulim F, Ahn SH, et al. Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants. J Virol 77: 6601-6612, 2003.","DOI":"10.1128\/JVI.77.12.6601-6612.2003"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kumar R. Review on hepatitis B virus precore\/core promoter mutations and their correlation with genotypes and liver disease severity. World J Hepatol 14: 708-718, 2022.","DOI":"10.4254\/wjh.v14.i4.708"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Zhang L, Jiang T, Yang Y, et al. Postpartum hepatitis and host immunity in pregnant women with chronic HBV infection. Front Immunol 13: 1112234, 2023.","DOI":"10.3389\/fimmu.2022.1112234"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. OuYang S, Geng Y, Qiu G, Deng Y, Deng H, Pan CQ. Postpartum hepatitis flares in mothers with chronic hepatitis B infection. Gastroenterol Rep (Oxf) 12: goae091, 2024.","DOI":"10.1093\/gastro\/goae091"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kawamura H, Matsuura K, Ito K, et al. Efficacy of antiviral therapy for the prevention of mother-to-child transmission of hepatitis B virus and the risk of postpartum hepatitis flare after discontinuation of antiviral therapy. Hepatol Res 54: 1106-1112, 2024.","DOI":"10.1111\/hepr.14048"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Li M, Sun F, Bi X, et al. Effects of antiviral therapy and drug withdrawal on postpartum hepatitis in pregnant women with chronic HBV infection. Hepatol Int 17: 42-51, 2023.","DOI":"10.1007\/s12072-022-10412-w"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Terrault NA, Lok AS, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 67: 1560-1599, 2018.","DOI":"10.1002\/hep.29800"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol 67: 370-398, 2017.","DOI":"10.1016\/j.jhep.2017.03.021"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kumar M, Abbas Z, Azami M, et al. Asian Pacific Association for the Study of the Liver (APASL) guidelines: hepatitis B virus in pregnancy. Hepatol Int 16: 211-253, 2022.","DOI":"10.1007\/s12072-021-10285-5"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Yu L, Zhang B, Cheng M, et al. Quantitative assessment of mutations in hepatitis B virus genome with liver cirrhosis and hepatocellular carcinoma development. Oncotarget 2016 [Internet]. Available from: https:\/\/www.oncotarget.com\/article\/9417\/text\/","DOI":"10.18632\/oncotarget.9417"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Liu CJ, Kao JH, Lai MY, Chen PJ, Chen DS. Precore\/core promoter mutations and genotypes of hepatitis B virus in chronic hepatitis B patients with fulminant or subfulminant hepatitis. J Med Virol 72: 545-550, 2004.","DOI":"10.1002\/jmv.20024"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Funk AL, Lu Y, Yoshida K, et al. Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis. Lancet Infect Dis 21: 70-84, 2021.","DOI":"10.1016\/S1473-3099(20)30586-7"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Lin Y, Liu Y, Ding G, et al. Efficacy of tenofovir in preventing perinatal transmission of HBV infection in pregnant women with high viral loads. Sci Rep 8: 15514, 2018.","DOI":"10.1038\/s41598-018-33833-w"},{"key":"20","unstructured":"20. Revill PA, Chisari FV, Block JM, et al. A global scientific strategy to cure hepatitis B. Lancet Gastroenterol Hepatol 4: 545-558, 2019."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/13\/65_6294-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T03:29:25Z","timestamp":1783135765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/13\/65_6294-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":20,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6294-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"article-number":"6294-25"}}